Valneva SE - Company Profile
Powered by 
All the data and insights you need on Valneva SE in one report.
$295
- Save hours of research time and resources with
our up-to-date Valneva SE Strategy Report
- Understand Valneva SE position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Valneva SE’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Valneva SE's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Thomas Lingelbach
President; Chief Executive Officer Executive BoardMr. Thomas Lingelbach has been the President and the Chief Executive Officer of Valneva since 2013. He served as the President and Chief Executive Officer at Intercell from 2006 until 2013. Mr. Lingelbach held various positions of increasing international responsibility in the pharma and vaccine industry. He joined as Intercell's Managing Director (MD) - Germany from Novartis Vaccine & Diagnostics and later served as Vice President Global Industrial Operations and MD of Chiron-Behring.
Franck Grimaud
Director - General; Chief Business Officer Executive BoardMr. Franck Grimaud has been the Director-General and the Chief Business Officer of the company since May 2013. He co-founded Vivalis in 1999 serving as its Chief Executive Officer and President du Directoire. Mr. Grimaud has more than 20 years of experience in various industries.
Peter Buhler
Chief Financial Officer Senior ManagementMr. Peter Buhler has been the Chief Financial Officer of the company since 2022. Prior to this, he served as the Chief Financial Officer at Quotient and Group Chief Financial Officer at Zaluvida AG and Stallergenes Greer Plc.
Juan Carlos Jaramillo, M.D.
Chief Medical Officer Senior ManagementDr. Juan Carlos Jaramillo has been the Chief Medical Officer of the company since October 2020. Prior to this, he served in various organization that include Celsion, Daiichi Sankyo, GlaxoSmithKline and Grunenthal.
Dipal Patel
Chief Commercial Officer Senior ManagementMs. Dipal Patel has been the Chief Commercial Officer of the company since November 2022. Prior to this she served as a Global Commercial Head of GSK’s shingles vaccine.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer